Vera Therapeutics, Inc.
NASDAQVera Therapeutics enters the second week of July with a striking split: five analysts raised price targets on the same day the stock jumped 7%, yet short sellers are sitting on nearly 19% of the float with no sign of covering. The analyst activity on July 8 was unusually concentrated. BofA Securities lifted its target from $65 to $70, maintaining Buy. Guggenheim made a larger move…
Snapshot as of 8 Jul 2026
Vera Therapeutics enters the second week of July with a striking split: five analysts raised price targets on the same day the stock jumped 7%, yet short sellers are sitting on nearly 19% of the float with no sign of…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VERA — free to start on ORTEX.
Sign up for free →Open VERA on ORTEX